BeOne Medicines (BEIGF) Gross Margin Growth (1y) (2018 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) Gross Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 32.00 |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 292.00 |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | -396.00 |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | -391.00 |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | -144.00 |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 257.00 |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 21.00 |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | -173.00 |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 228.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 228.00 |
| Mar 31, 2026 | 372.00 |
| Dec 31, 2025 | 473.00 |
| Sep 30, 2025 | 310.00 |
| Jun 30, 2025 | 235.00 |
| Mar 31, 2025 | 185.00 |
| Dec 31, 2024 | 245.00 |
| Sep 30, 2024 | -469.00 |
| Jun 30, 2024 | 126.00 |
| Mar 31, 2024 | 164.00 |
| Dec 31, 2023 | 266.00 |
| Sep 30, 2023 | 742.00 |
| Jun 30, 2023 | 471.00 |
| Mar 31, 2023 | 301.00 |
| Dec 31, 2022 | 334.00 |
| Sep 30, 2022 | 322.00 |
| Jun 30, 2022 | 334.00 |
| Mar 31, 2022 | -1,588.00 |
| Dec 31, 2021 | -163.00 |
| Sep 30, 2021 | 22.00 |